DNA RNA and Cells

27 Jun 2017 Crestovo Doses Patients in PRISM 3, a Clinical Trial of CP101, a Microbiome Therapy for the Prevention of Recurrent Clostridium difficile Infection
27 Jun 2017 bluebird bio Announces Topline Interim Clinical Data from Starbeam Study of Lenti-D™ Drug Product in Cerebral Adrenoleukodystrophy (CALD)
26 Jun 2017 Alnylam Reports New Positive Clinical Results for Givosiran (ALN-AS1), an Investigational RNAi Therapeutic for the Treatment of Acute Hepatic Porphyrias
23 Jun 2017 bluebird bio Presents New Data from HGB-205 Study of LentiGlobinTM Drug Product in Patients with Transfusion-Dependent β-Thalassemia (TDT) and Severe Sickle Cell Disease (SCD) at European Hematology Association (EHA) Annual Meeting
23 Jun 2017 bluebird bio Announces Early Data from Phase 3 Northstar-2 (HGB-207) Study of LentiGlobinTM Drug Product at European Hematology Association (EHA) Annual Meeting
23 Jun 2017 Novartis pivotal CTL019 6-month follow-up data show durable remission rates in children, young adults with r/r B-cell ALL
23 Jun 2017 mRNA Vaccines & Therapeutics: are you ready to be on the ground floor of the next big new therapeutic modality?
22 Jun 2017 Enrollment in Phase 1/2a Study of IONIS-HTT Rx in Patients with Huntington's Disease Completed and Open-Label Extension Study to Open in 2H 2017
21 Jun 2017 Celyad reports promising early results at first dose level of the solid arm of the THINK trial
21 Jun 2017 Synlogic™ Doses First Subject in Phase 1 Trial of Novel Class of Synthetic Biotic™ Medicines
21 Jun 2017 Unum Therapeutics Announces Active Investigational New Drug (IND) Application for ACTR707 in Combination with Rituximab in Patients with Relapsed/Refractory B-cell Lymphoma
21 Jun 2017 Cell Medica acquires WT1 cancer immunotherapy from Cell and Gene Therapy Catapult
20 Jun 2017 Seattle Genetics Discontinues Phase 3 CASCADE Trial of Vadastuximab Talirine (SGN-CD33A) in Frontline Acute Myeloid Leukemia
20 Jun 2017 TCR2 Therapeutics Presents Positive Solid Tumor Data for its Novel TRuC™ Engineered T Cell Therapies at the World Preclinical Congress
19 Jun 2017 TxCell appoints Lentigen Technology, Inc. to manufacture the lentiviral vector for its first CAR-Treg program in transplant rejection
18 Jun 2017 Juno Therapeutics Presents TRANSCEND NHL 001 Trial Data at International Conference on Malignant Lymphoma
17 Jun 2017 Sirnaomics Advances Leading siRNA Therapeutic Candidate, STP705, for Treatment of Liver Fibrosis
15 Jun 2017 GenSight Biologics Reports Long-Term Positive Safety and Visual Acuity Results at Week 96 in Phase I/II Study of GS010 for the Treatment of Leber’s Hereditary Optic Neuropathy (LHON)
13 Jun 2017 Nature Medicine Reports Elimination of Large Tumors in Mice by Messenger RNA-Encoded Bispecific Antibodies
12 Jun 2017 Seres Therapeutics Initiates SER-109 Phase 3 Study in Patients with Multiply Recurrent C. difficile Infection
12 Jun 2017 CARMA Therapeutics Closes Initial Funding to Advance Chimeric Antigen Receptor Macrophages (CARMA) to Treat Solid Tumors
12 Jun 2017 Regulus Announces Pipeline Updates and Advancements
11 Jun 2017 AGTC Announces Topline Safety Data for X-Linked Retinoschisis Phase 1/2 Study
11 Jun 2017 Novartis presents data demonstrating efficacy of AMG 334 (erenumab) in migraine prevention at the American Headache Society Annual Meeting
07 Jun 2017 Rebiotix Data Presented at ASM Microbe 2017 Show RBX2660 Treated Patients' Clinical Success Correlates with Improved Microbiome Diversity

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing